Literature DB >> 17471237

Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.

A Vincent1, M Perrais, J-L Desseyn, J-P Aubert, P Pigny, I Van Seuningen.   

Abstract

The human genes MUC2, MUC5AC, MUC5B and MUC6 are clustered on chromosome 11 and encode large secreted gel-forming mucins. The frequent occurrence of their silencing in cancers and the GC-rich structure of their promoters led us to study the influence of epigenetics on their expression. Pre- and post-confluent cells were treated with demethylating agent 5-aza-2'-deoxycytidine and histone deacetylase (HDAC) inhibitor, trichostatin A. Mapping of methylated cytosines was performed by bisulfite-treated genomic DNA sequencing. Histone modification status at the promoters was assessed by chromatin immunoprecipitation assays. Our results indicate that MUC2 was regulated by site-specific DNA methylation associated with establishment of a repressive histone code, whereas hypermethylation of MUC5B promoter was the major mechanism responsible for its silencing. DNA methyltransferase 1 was identified by small interfering RNA approach as a regulator of MUC2 and MUC5B endogenous expression that was potentiated by HDAC2. MUC2 and MUC5B epigenetic regulation was cell-specific, depended on cell differentiation status and inhibited their activation by Sp1. The expression of MUC5AC was rarely influenced by epigenetic mechanisms and methylation of MUC6 promoter was not correlated to its silencing. In conclusion, this study demonstrates the important role for methylation and/or histone modifications in regulating the 11p15 mucin genes in epithelial cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471237     DOI: 10.1038/sj.onc.1210479

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

1.  Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.

Authors:  Noriyuki Omura; Margaret Griffith; Audrey Vincent; Ang Li; Seung-Mo Hong; Kimberly Walter; Michael Borges; Michael Goggins
Journal:  Mol Cancer Res       Date:  2010-06-08       Impact factor: 5.852

2.  Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.

Authors:  Haroon Asif Choudry; Arun Mavanur; Mark E O'Malley; Herbert J Zeh; Z Sheng Guo; David L Bartlett
Journal:  Ann Surg Oncol       Date:  2012-05       Impact factor: 5.344

3.  The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling.

Authors:  Yeon Ho Choi; Sang-Nam Lee; Hiroki Aoyagi; Yasundo Yamasaki; Jung-Yoon Yoo; Boryung Park; Dong Min Shin; Ho-Geun Yoon; Joo-Heon Yoon
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

4.  Abnormal expression of Muc5b in Cftr-null mice and in mammary tumors of MMTV-ras mice.

Authors:  Hélène Valque; Valérie Gouyer; Marie-Odile Husson; Frédéric Gottrand; Jean-Luc Desseyn
Journal:  Histochem Cell Biol       Date:  2011-10-18       Impact factor: 4.304

Review 5.  Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.

Authors:  Christopher M Evans; Tasha E Fingerlin; Marvin I Schwarz; David Lynch; Jonathan Kurche; Laura Warg; Ivana V Yang; David A Schwartz
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

6.  Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.

Authors:  Kiyoshi Yamaguchi; Maria Cekanova; Michael F McEntee; Joo-Heon Yoon; Susan M Fischer; Ingrid B Renes; Isabelle Van Seuningen; Seung Joon Baek
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

Review 7.  Epigenetics in lung fibrosis: from pathobiology to treatment perspective.

Authors:  Britney A Helling; Ivana V Yang
Journal:  Curr Opin Pulm Med       Date:  2015-09       Impact factor: 3.155

Review 8.  Current evidence for histone deacetylase inhibitors in pancreatic cancer.

Authors:  Ioannis Koutsounas; Constantinos Giaginis; Efstratios Patsouris; Stamatios Theocharis
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

9.  Potential prognostic biomarkers of pancreatic cancer.

Authors:  Kathryn T Chen; Phillip D Kim; Kelly A Jones; Karthik Devarajan; Bhavinkumar B Patel; John P Hoffman; Hormoz Ehya; Min Huang; James C Watson; Jeffrey L Tokar; Anthony T Yeung
Journal:  Pancreas       Date:  2014-01       Impact factor: 3.327

10.  MUC2 expression is an adverse prognostic factor in superficial gastroesophageal adenocarcinomas.

Authors:  Jon M Davison; Shane T Ellis; Tyler J Foxwell; James D Luketich; Michael K Gibson; Shih-Fan Kuan; Katie S Nason
Journal:  Hum Pathol       Date:  2013-10-30       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.